Results 111 to 120 of about 43,044 (314)

International Classification of Retinopathy of Prematurity, Third Edition.

open access: yesOphthalmology (Rochester, Minn.), 2021
M. Chiang   +34 more
semanticscholar   +1 more source

Visual acuity outcomes up to 12 years and risk factors for visual impairment in a national cohort of extremely preterm born children – The Extremely Preterm Infants in Sweden Study (EXPRESS)

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The Extremely Preterm Infants in Sweden Study (EXPRESS) followed a national cohort of extremely preterm born (EPT, i.e. <27 weeks) children until 12 years of age. This study aimed to investigate the longitudinal development of visual acuity (VA) in children born EPT, explore the predictive value of early visual assessments, and ...
Despoina Tsamadou   +12 more
wiley   +1 more source

Individual Risk Prediction for Sight-Threatening Retinopathy of Prematurity Using Birth Characteristics

open access: yesJAMA ophthalmology, 2019
This cohort study creates and validates an easy-to-use prediction model using only birth characteristics and describes a continuous hazard function for retinopathy of prematurity treatment.
A. Pivodic   +12 more
semanticscholar   +1 more source

Impact of anti‐VEGF therapy versus laser therapy on mortality and treatment outcomes in retinopathy of prematurity: A systematic review and meta‐analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Retinopathy of prematurity (ROP) is a major cause of childhood blindness, and selecting the optimal treatment between anti‐vascular endothelial growth factor (anti‐VEGF) and laser therapy is crucial. Understanding their impact on key outcomes, particularly mortality, is essential for informed clinical decision‐making.
Wei‐De Wang   +10 more
wiley   +1 more source

Customizing AI‐based screening with real‐world data: Practical insights from diabetic retinopathy

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Diabetic retinopathy (DR) is a leading cause of vision loss in middle‐aged adults globally. Although artificial intelligence (AI)‐based screening tools like IDx‐DR (classification) and Thirona RetCAD (regression) have shown high sensitivity in controlled settings, real‐world screening faces challenges due to missing or low‐quality ...
Broder Poschkamp   +17 more
wiley   +1 more source

Screening and treatments using telemedicine in retinopathy of prematurity

open access: yesEye and Brain, 2016
Aristomenis Thanos,1 Yoshihiro Yonekawa,1,2 Bozho Todorich,1 Darius M Moshfeghi,3 Michael T Trese1 1Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, MI, 2Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School ...
Thanos A   +4 more
doaj  

Retinopathy of Prematurity: How to prevent retinopathy of prematurity in Indonesia? [PDF]

open access: yes, 2021
Summary Retinopathy of prematurity (ROP) is a serious eye disease seen in preterm infants that can cause blindness. In this thesis, we tried to answer the following questions. 1. Is this disease seen more frequently in patients in Indonesia compared to High-Income Countries (HIC), and are clinical characteristics different? 2.
openaire   +1 more source

Characterising PRPF31‐associated retinal dystrophy: Clinical insights from baseline data in a natural history study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To characterise the baseline clinical features and genotypes of adults with pre‐mRNA processing factor 31 (PRPF31)‐associated retinal dystrophy (RD) enrolled in a prospective, multicentre 4‐year natural history study, and to explore correlations between selected baseline parameters.
Kathrine Olaussen Eriksen   +6 more
wiley   +1 more source

Pharmacological Approach for Treatment of Retinopathy of Prematurity

open access: yesTürk Oftalmoloji Dergisi, 2012
Current standard of screening examination for retinopathy of prematurity (ROP) is determined in international guidelines. The criteria for classification and therapy are also determined in international guidelines, and currently, retinal laser ...
İmren Akkoyun
doaj   +1 more source

Home - About - Disclaimer - Privacy